位置:首页 > 蛋白库 > DLL4_MOUSE
DLL4_MOUSE
ID   DLL4_MOUSE              Reviewed;         686 AA.
AC   Q9JI71; Q9DBU9; Q9JHZ7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Delta-like protein 4;
DE   AltName: Full=Drosophila Delta homolog 4;
DE            Short=Delta4;
DE   Flags: Precursor;
GN   Name=Dll4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adipose tissue;
RX   PubMed=10837024;
RA   Shutter J.R., Scully S., Fan W., Richards W.G., Kitajewski J.,
RA   Deblandre G.A., Kintner C.R., Stark K.L.;
RT   "Dll4, a novel Notch ligand expressed in arterial endothelium.";
RL   Genes Dev. 14:1313-1318(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=11134954; DOI=10.1093/oxfordjournals.jbchem.a002832;
RA   Yoneya T., Tahara T., Nagao K., Yamada Y., Yamamoto T., Miyatani S.,
RA   Nishikawa M.;
RT   "Molecular cloning of Delta-4, a new mouse and human Notch ligand.";
RL   J. Biochem. 129:27-34(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=129/Ola;
RA   Mailhos C., Lewis J., Ish-Horowicz D.;
RT   "A novel Notch ligand expressed in embryonic and tumour vasculation.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and Czech II; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN RETINAL DEVELOPMENT, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=22323600; DOI=10.1073/pnas.1115767109;
RA   Luo H., Jin K., Xie Z., Qiu F., Li S., Zou M., Cai L., Hozumi K.,
RA   Shima D.T., Xiang M.;
RT   "Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress
RT   photoreceptor cell fates of early retinal progenitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E553-E562(2012).
CC   -!- FUNCTION: Involved in the Notch signaling pathway as Notch ligand
CC       (PubMed:11134954). Activates NOTCH1 and NOTCH4. Involved in
CC       angiogenesis; negatively regulates endothelial cell proliferation and
CC       migration and angiogenic sprouting (By similarity). Essential for
CC       retinal progenitor proliferation. Required for suppressing rod fates in
CC       late retinal progenitors as well as for proper generation of other
CC       retinal cell types (PubMed:22323600). During spinal cord neurogenesis,
CC       inhibits V2a interneuron fate (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NR61, ECO:0000269|PubMed:11134954,
CC       ECO:0000269|PubMed:22323600}.
CC   -!- SUBUNIT: Interacts with NOTCH4. Interacts (via N-terminal DSL and MNNL
CC       domains) with NOTCH1 (via EGF-like domains).
CC       {ECO:0000250|UniProtKB:D3ZHH1}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in vascular endothelium. Expressed in
CC       retina at least during embryogenesis. {ECO:0000269|PubMed:22323600}.
CC   -!- DEVELOPMENTAL STAGE: At 14.5, expressed within the retina outer
CC       neuroblastic layer. {ECO:0000269|PubMed:22323600}.
CC   -!- DISRUPTION PHENOTYPE: Conditional knockdowns in retinal progenitors
CC       have thinner retinas with occasional regions abnormally organized into
CC       rosette-like structures in the outer nuclear layer and an optic nerve
CC       with a reduced diameter. {ECO:0000269|PubMed:22323600}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF253469; AAF76428.1; -; mRNA.
DR   EMBL; AF273454; AAF78785.1; -; mRNA.
DR   EMBL; AB043893; BAB18580.1; -; mRNA.
DR   EMBL; AK004739; BAB23520.1; -; mRNA.
DR   EMBL; AL929318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042497; AAH42497.1; -; mRNA.
DR   EMBL; BC049130; AAH49130.1; -; mRNA.
DR   CCDS; CCDS16600.1; -.
DR   PIR; JC7569; JC7569.
DR   RefSeq; NP_062327.2; NM_019454.3.
DR   AlphaFoldDB; Q9JI71; -.
DR   SMR; Q9JI71; -.
DR   BioGRID; 207669; 3.
DR   IntAct; Q9JI71; 4.
DR   STRING; 10090.ENSMUSP00000099575; -.
DR   GlyGen; Q9JI71; 5 sites.
DR   iPTMnet; Q9JI71; -.
DR   PhosphoSitePlus; Q9JI71; -.
DR   PaxDb; Q9JI71; -.
DR   PRIDE; Q9JI71; -.
DR   ProteomicsDB; 277468; -.
DR   ABCD; Q9JI71; 3 sequenced antibodies.
DR   Antibodypedia; 5995; 882 antibodies from 45 providers.
DR   DNASU; 54485; -.
DR   Ensembl; ENSMUST00000102517; ENSMUSP00000099575; ENSMUSG00000027314.
DR   GeneID; 54485; -.
DR   KEGG; mmu:54485; -.
DR   UCSC; uc008ltr.2; mouse.
DR   CTD; 54567; -.
DR   MGI; MGI:1859388; Dll4.
DR   VEuPathDB; HostDB:ENSMUSG00000027314; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000157441; -.
DR   HOGENOM; CLU_012574_1_0_1; -.
DR   InParanoid; Q9JI71; -.
DR   OMA; CTEQNGY; -.
DR   OrthoDB; 406049at2759; -.
DR   PhylomeDB; Q9JI71; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-MMU-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   BioGRID-ORCS; 54485; 2 hits in 73 CRISPR screens.
DR   PRO; PR:Q9JI71; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9JI71; protein.
DR   Bgee; ENSMUSG00000027314; Expressed in interventricular septum and 167 other tissues.
DR   Genevisible; Q9JI71; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:MGI.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IDA:MGI.
DR   GO; GO:0001525; P:angiogenesis; IMP:MGI.
DR   GO; GO:0072554; P:blood vessel lumenization; IMP:BHF-UCL.
DR   GO; GO:0001974; P:blood vessel remodeling; IMP:BHF-UCL.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0035912; P:dorsal aorta morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:MGI.
DR   GO; GO:1903588; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:MGI.
DR   GO; GO:0003344; P:pericardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:MGI.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061074; P:regulation of neural retina development; IMP:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IMP:MGI.
DR   GO; GO:0030217; P:T cell differentiation; IDA:UniProtKB.
DR   GO; GO:0060579; P:ventral spinal cord interneuron fate commitment; ISS:UniProtKB.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 4.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 9.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 8.
PE   1: Evidence at protein level;
KW   Angiogenesis; Cell membrane; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Neurogenesis;
KW   Notch signaling pathway; Reference proteome; Repeat; Sensory transduction;
KW   Signal; Transmembrane; Transmembrane helix; Vision.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..686
FT                   /note="Delta-like protein 4"
FT                   /id="PRO_0000007513"
FT   TOPO_DOM        27..532
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        533..553
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        554..686
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          174..218
FT                   /note="DSL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DOMAIN          219..252
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          253..283
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          285..323
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          325..361
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          364..401
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          403..439
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          441..477
FT                   /note="EGF-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          481..519
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          186..188
FT                   /note="Interaction with Notch1"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   REGION          192..196
FT                   /note="Interaction with Notch1"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   SITE            111
FT                   /note="Interaction with Notch1"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   SITE            217
FT                   /note="Interaction with Notch1"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   CARBOHYD        109
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   CARBOHYD        162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        51..55
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   DISULFID        62..75
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   DISULFID        176..185
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DISULFID        189..201
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DISULFID        209..218
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DISULFID        223..234
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        227..240
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        242..251
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        254..265
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   DISULFID        260..271
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1"
FT   DISULFID        273..282
FT                   /evidence="ECO:0000250|UniProtKB:D3ZHH1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        289..301
FT                   /evidence="ECO:0000250"
FT   DISULFID        295..311
FT                   /evidence="ECO:0000250"
FT   DISULFID        313..322
FT                   /evidence="ECO:0000250"
FT   DISULFID        329..340
FT                   /evidence="ECO:0000250"
FT   DISULFID        334..349
FT                   /evidence="ECO:0000250"
FT   DISULFID        351..360
FT                   /evidence="ECO:0000250"
FT   DISULFID        367..378
FT                   /evidence="ECO:0000250"
FT   DISULFID        372..389
FT                   /evidence="ECO:0000250"
FT   DISULFID        391..400
FT                   /evidence="ECO:0000250"
FT   DISULFID        407..418
FT                   /evidence="ECO:0000250"
FT   DISULFID        412..427
FT                   /evidence="ECO:0000250"
FT   DISULFID        429..438
FT                   /evidence="ECO:0000250"
FT   DISULFID        445..456
FT                   /evidence="ECO:0000250"
FT   DISULFID        450..465
FT                   /evidence="ECO:0000250"
FT   DISULFID        467..476
FT                   /evidence="ECO:0000250"
FT   DISULFID        485..496
FT                   /evidence="ECO:0000250"
FT   DISULFID        490..507
FT                   /evidence="ECO:0000250"
FT   DISULFID        509..518
FT                   /evidence="ECO:0000250"
FT   CONFLICT        419
FT                   /note="Q -> L (in Ref. 1; AAF76428 and 3; AAF78785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        527..528
FT                   /note="SF -> CS (in Ref. 3; AAF78785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        627
FT                   /note="G -> S (in Ref. 1; AAF76428 and 3; AAF78785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        639..649
FT                   /note="LGEKVPLRLHS -> IGQGATSVTH (in Ref. 3; AAF78785)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   686 AA;  74991 MW;  E7DD4FC15C4AFFBA CRC64;
     MTPASRSACR WALLLLAVLW PQQRAAGSGI FQLRLQEFVN QRGMLANGQS CEPGCRTFFR
     ICLKHFQATF SEGPCTFGNV STPVLGTNSF VVRDKNSGSG RNPLQLPFNF TWPGTFSLNI
     QAWHTPGDDL RPETSPGNSL ISQIIIQGSL AVGKIWRTDE QNDTLTRLSY SYRVICSDNY
     YGESCSRLCK KRDDHFGHYE CQPDGSLSCL PGWTGKYCDQ PICLSGCHEQ NGYCSKPDEC
     ICRPGWQGRL CNECIPHNGC RHGTCSIPWQ CACDEGWGGL FCDQDLNYCT HHSPCKNGST
     CSNSGPKGYT CTCLPGYTGE HCELGLSKCA SNPCRNGGSC KDQENSYHCL CPPGYYGQHC
     EHSTLTCADS PCFNGGSCRE RNQGSSYACE CPPNFTGSNC EKKVDRCTSN PCANGGQCQN
     RGPSRTCRCR PGFTGTHCEL HISDCARSPC AHGGTCHDLE NGPVCTCPAG FSGRRCEVRI
     THDACASGPC FNGATCYTGL SPNNFVCNCP YGFVGSRCEF PVGLPPSFPW VAVSLGVGLV
     VLLVLLVMVV VAVRQLRLRR PDDESREAMN NLSDFQKDNL IPAAQLKNTN QKKELEVDCG
     LDKSNCGKLQ NHTLDYNLAP GLLGRGGMPG KYPHSDKSLG EKVPLRLHSE KPECRISAIC
     SPRDSMYQSV CLISEERNEC VIATEV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024